Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.
Molejon MI, Tellechea JI, Loncle C, Gayet O, Gilabert M, Duconseil P, Lopez-Millan MB, Moutardier V, Gasmi M, Garcia S, Turrini O, Ouaissi M, Poizat F, Dusetti N, Iovanna J.
Molejon MI, et al. Among authors: tellechea ji.
Oncotarget. 2015 Apr 10;6(10):7408-23. doi: 10.18632/oncotarget.3510.
Oncotarget. 2015.
PMID: 25797268
Free PMC article.